glp-1 europe Receptor Agonist Market Size & Outlook, 2033 GLP-1 Receptor Agonist Market Size
Description
FEHB Plan Coverage Weight-loss drugs are classified as GLP-1 (glucagon-like peptide-1) receptor agonists, and the ones approved by the FDA include Qsymia, Contrave, Saxenda, Wegovy, and Zepbound
doi: 10.1210/clinem/dgz140 174 Ten KulveJSVeltmanDJVan BloemendaalLGrootPFCRuhHGBarkhofFet al
However, their effect on ovarian cancer, which is a significant health concern for women worldwide, has been unclear
Treating obesity can help reverse or prevent these complications from developing, which is an important factor when weighing treatment options
